| Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin NDM Knowler WC1, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA New England Journal of Medicine 346 (6), 393-403, 2002 | 25345* | 2002 |
| The Diabetes Prevention Program (DPP): description of lifestyle intervention DPPDPPR Group Diabetes Care 25 (12), 2165-71, 2002 | 2071 | 2002 |
| The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial FS Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S Annals of Internal Medicine 142 (8), 611-9, 2005 | 1295 | 2005 |
| Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells … AM Schmidt, O Hori, JX Chen, JF Li, J Crandall, J Zhang, R Cao, SD Yan, ... Journal of Clinical Investigation 96 (3), 1395, 1995 | 1205 | 1995 |
| Prevention of diabetes in women with a history of gestational diabetes: Effects of metformin and lifestyle interventions KSE Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X ... Journal of Clnical Endocrinology and Metabolism 93 (12), 4774-9, 2008 | 1040* | 2008 |
| Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy H Vlassara, W Cai, J Crandall, T Goldberg, R Oberstein, V Dardaine, ... Proceedings of the National Academy of Sciences 99 (24), 15596-15601, 2002 | 849 | 2002 |
| Impact of intensive lifestyle and metformin therapy on cardiovascular risk factors in the Diabetes Prevention Program TM Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, ... Diabetes Care 28 (4), 888-94, 2005 | 769* | 2005 |
| The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes TDPPR Group Diabetes Care 22 (4), 623-34, 1999 | 706 | 1999 |
| Statin therapy and risk of developing type 2 diabetes: a meta-analysis SN Rajpathak, DJ Kumbhani, J Crandall, N Barzilai, M Alderman, ... Diabetes care 32 (10), 1924-1929, 2009 | 622 | 2009 |
| Prevention of Type 2 diabetes with troglitazone in the Diabetes Prevention program KSE Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA ... Diabetes 54 (4), 1150-6, 2005 | 583* | 2005 |
| Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. KSE Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, ... Lancet 379 (9833), 2243-51, 2012 | 557 | 2012 |
| Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study DPPR Group Diabetes Care 35 (4), 731-7, 2012 | 477 | 2012 |
| The role of iron in type 2 diabetes in humans SN Rajpathak, JP Crandall, J Wylie-Rosett, GC Kabat, TE Rohan, FB Hu Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 671-681, 2009 | 461 | 2009 |
| Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance BCE Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E ... Diabetes 54 (5), 1566-72., 2005 | 440* | 2005 |
| Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity A Sambola, J Osende, J Hathcock, M Degen, Y Nemerson, V Fuster, ... Circulation 107 (7), 973-977, 2003 | 438 | 2003 |
| The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program DPPR Group Diabetic Medicine 24 (2), 137-44, 2007 | 429 | 2007 |
| The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes AR Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y ... J Gerontol A Biol Sci Med Sci 61 (10), 1075-81, 2006 | 346 | 2006 |
| The prevention of type 2 diabetes JP Crandall, WC Knowler, SE Kahn, D Marrero, JC Florez, GA Bray, ... Nature Clinical Practice Endocrinology & Metabolism 4 (7), 382-393, 2008 | 344 | 2008 |
| The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group TDPPR Group Diabetes Care 23 (11), 1619-29, 2000 | 344* | 2000 |
| Pilot study of resveratrol in older adults with impaired glucose tolerance JP Crandall, V Oram, G Trandafirescu, M Reid, P Kishore, M Hawkins, ... The Journals of Gerontology Series A: Biological Sciences and Medical …, 2012 | 340 | 2012 |
